jw van zyl ıncRegulatory and market access
Get the regulatory structure right before the commercial terms are fixed.
Regulatory exposure in South Africa is usually created before a product arrives, in the choice of market-entry structure and in how regulatory responsibility is divided between the parties. Those decisions are contractual and structural, and they are difficult to unwind once commercial terms are signed.
Who this is for
Applicants, registration holders, licensees, authorised representatives, importers, distributors and local representatives. Typically instructed by regulatory affairs, market access, quality, and country or commercial leads.
Scope
What can be instructed
- Regulatory pathway as a legal question
- Whether a reliance or recognition route is available for a product, what relying on it commits the applicant to, and how that constrains the commercial timetable.
- Market-entry and responsible-party structures
- Which entity applies, which holds the registration once granted, and the legal relationship between that party, the local representative, the importer and the distributor. The relevant status differs by product class and is identified accordingly.
- Allocation of regulatory responsibility
- How regulatory obligations are divided across the parties by contract, including pharmacovigilance, quality, reporting and record-keeping, and where an agreement leaves an obligation unassigned.
- Advertising, promotion and industry codes
- Promotional review, interactions with healthcare professionals and institutions, sponsorships, grants and patient-support programmes.
- Recalls, safety and product liability
- Recall and field-safety obligations as contractual and liability events, and how they sit against supply, distribution and quality terms.
- Public-sector and tender contracting
- Tender conditions, state supply arrangements and the contractual obligations that follow from award.
JW van Zyl Inc advises on regulatory pathways, structures and obligations where they give rise to legal, contractual or commercial consequences. The firm does not prepare regulatory dossiers or conduct scientific submissions. Where a mandate requires regulatory-affairs execution, the firm works alongside the client's regulatory function or separately appointed regulatory advisers.
Before you instruct
What helps the firm assess the matter
- The product and its regulatory classification.
- Whether a registration or approval exists in any reference jurisdiction.
- The intended local structure: own entity, local representative or appointed distributor.
- The commercial deadline the programme is working to.
Free tool
Before you instruct, work through the checklist
Use the South Africa market-entry checklist to identify the structural and regulatory questions a market entry raises before the commercial terms are agreed.